Early Return to School After Concussion Linked to Lower Symptom Burden
Study findings indicate that returning to school earlier may lead to a faster recovery after a concussion.
Study findings indicate that returning to school earlier may lead to a faster recovery after a concussion.
Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in Alzheimer disease and related dementias and how to improve clinical outcomes for patients from underrepresented groups.
Approval of the Alzheimer medication lecanemab comes after controversial approval in 2021 of aducanumab, which met with criticism over concerns about that drug’s effectiveness, safety, pricing
Joseph D. Dougherty, PhD discusses genetic compounds’ ability to clear amyloid-β from the brain in patients with Alzheimer disease.
Research findings support the use of vitamin D supplementation to help slow cognitive decline in Alzheimer dementia and reduce Parkinson disease symptom severity.
Researchers sought to evaluate how sustained attention relates to white matter maturation in children who are neurotypical and children with ADHD.
Recent FDA approvals include treatments for acute low back pain, postoperative nausea and vomiting, multiple myeloma, hemophilia B, and fibromyalgia pain.
As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed of processing (SOP) may help stall those effects.
Those with a family history or higher self-perceived risk are more likely to participate.
Neurogenic inflammation has been identified as a common mechanism between dry eye and migraines.